ArticleRoyal Society open science2018
Implications of asymptomatic carriers for infectious disease transmission and control.
Article in Royal Society open science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global epidemiology of asymptomatic colonisation of methicillin-resistantArchives of disease in childhood · 2024Pooled it
- Waterborne diseases and climate change.Nature reviews. Microbiology · 2026Review
- Environmental surveillance of pathogens in Africa.Applied and environmental microbiology · 2026Review
- Modelling the Effects of Treatment Failure on the Minor Outbreak Duration for Carrier-Related Infectious Disease.Epidemiologia (Basel, Switzerland) · 2026Article
- Dynamic behavior of a stochastic epidemic model for skin sores: theoretical and computational perspectives.Scientific reports · 2026Article
- The theory of epidemics with altruism.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Sample pooling approaches simulated under resource scarcity, lapses in testing capacity, and rapid processing demands for surveillance testing: a data-driven performance comparison.BMC infectious diseases · 2026Article
- A Unified Pathogenesis of Allergic Diseases; The Protein-Homeostasis-System Hypothesis.International journal of molecular sciences · 2025Review
- Article
- Treatment failure and the threshold of disease extinction.Infectious Disease Modelling · 2025Article
- Molecular epidemiology ofMicrobial genomics · 2025Article
- Genomic Characterization of Multidrug-Resistant Pathogenic Enteric Bacteria from Healthy Children in Osun State, Nigeria.Microorganisms · 2024Article
- A Low-Cost Early Warning Method for Infectious Diseases with Asymptomatic Carriers.Healthcare (Basel, Switzerland) · 2024Article
- Replicating superspreader dynamics with compartmental models.Scientific reports · 2023Article
- Amphibian infection tolerance to chytridiomycosis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023Review
- A multi-strain model with asymptomatic transmission: Application to COVID-19 in the US.Journal of theoretical biology · 2023Article
- The Transmission Dynamics of a Compartmental Epidemic Model for COVID-19 with the Asymptomatic Population via Closed-Form Solutions.Vaccines · 2022Article
- Selected commensals educate the intestinal vascular and immune system for immunocompetence.Microbiome · 2022Article
- The C-Terminal Domain ofPathogens (Basel, Switzerland) · 2022Article
- Lack of practical identifiability may hamper reliable predictions in COVID-19 epidemic models.Science advances · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For infectious pathogens such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.